APA (7th ed.) Citation

SS, S., J, M., TH, C., T, D., B, L., MJ, C., & JW, H. (2023). Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate. Journal of thrombosis and thrombolysis, 56(2), 360. https://doi.org/10.1007/s11239-023-02841-7

Chicago Style (17th ed.) Citation

SS, Sutton, Magagnoli J, Cummings TH, Dettling T, Lovelace B, Christoph MJ, and Hardin JW. "Correction to: Real-world Clinical Outcomes Among US Veterans with Oral Factor Xa Inhibitor-related Major Bleeding Treated with Andexanet Alfa or 4-factor Prothrombin Complex Concentrate." Journal of Thrombosis and Thrombolysis 56, no. 2 (2023): 360. https://doi.org/10.1007/s11239-023-02841-7.

MLA (9th ed.) Citation

SS, Sutton, et al. "Correction to: Real-world Clinical Outcomes Among US Veterans with Oral Factor Xa Inhibitor-related Major Bleeding Treated with Andexanet Alfa or 4-factor Prothrombin Complex Concentrate." Journal of Thrombosis and Thrombolysis, vol. 56, no. 2, 2023, p. 360, https://doi.org/10.1007/s11239-023-02841-7.